文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

自适应分钟通气量+IntelliCycle通气模式在轻中度急性呼吸窘迫综合征患者中的临床应用

[Clinical application of adaptive minute ventilation + IntelliCycle ventilation mode in patients with mild-to-moderate acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论在轻中度ARDS患者中,与SIMV+PSV相比,AMV+IntelliCycle模式可缩短机械通气时间、降低机械功率并减少报警与手动操作次数,但PaCO2更高。

该研究纳入锦州医科大学附属第一医院ICU 2018年2月至2019年2月收治的轻中度ARDS患者,随机分为SIMV+PSV组和AMV+IntelliCycle组,最终80例纳入分析(每组40例)。AMV+IntelliCycle组在设定分钟通气量、FiO2和PEEP后开启全自动模式,预设分钟通气量百分比为120%;SIMV+PSV组设置通气频率12-20次/min、吸呼比1:1-2、吸气峰压限制35-45 cmH2O等。结果显示,与SIMV+PSV相比,AMV+IntelliCycle可缩短机械通气时间(106.35±55.03 h vs 136.50±73.78 h)、减少呼吸机报警次数(10.35±5.87次 vs 13.93±6.87次)和手动操作次数(4.25±2.01次 vs 6.83±3.75次),并降低机械功率(12.88±4.67 J/min vs 16.35±5.04 J/min),均P<0.05;但AMV+IntelliCycle组PaCO2显著高于SIMV+PSV组(41.58±6.81 mmHg vs 38.45±5.77 mmHg,P<0.05)。

要点

  • 在轻中度ARDS患者中,AMV+IntelliCycle模式较SIMV+PSV缩短机械通气时间(106.35±55.03 h vs 136.50±73.78 h,P<0.05)。
  • AMV+IntelliCycle模式减少呼吸机报警次数(10.35±5.87次 vs 13.93±6.87次)和手动操作次数(4.25±2.01次 vs 6.83±3.75次),均P<0.05。
  • AMV+IntelliCycle模式降低机械功率(12.88±4.67 J/min vs 16.35±5.04 J/min,P<0.05)。
  • AMV+IntelliCycle组PaCO2显著高于SIMV+PSV组(41.58±6.81 mmHg vs 38.45±5.77 mmHg,P<0.05)。
  • 两组间分钟通气量、吸气峰压、P0.1、静态顺应性、潮气量、呼吸功和时间常数无显著差异(均P>0.05)。

适用人群与场景

  • 纳入锦州医科大学附属第一医院ICU 2018年2月至2019年2月收治的轻中度ARDS患者。
  • 排除因死亡、放弃治疗、气管插管意外脱管等退出研究者。

处置流程与药物剂量

  • 所有患者入院后给予机械通气、抗感染、镇痛镇静、营养支持及原发病对症治疗,使用SV800呼吸机。
  • AMV+IntelliCycle组:设定分钟通气量(VE)、吸入氧浓度(FiO2)和呼气末正压(PEEP)后开启全自动模式,预设VE百分比为120%。
  • SIMV+PSV组:通气频率12-20次/min,吸呼比1:1-2,吸气峰压(PIP)限制水平35-45 cmH2O(1 cmH2O=0.098 kPa),FiO2和PEEP设置与AMV+IntelliCycle组相同,触发流量设为2 L/min。

研究设计与关键结果

  • 研究类型为随机对照研究(随机数字表法),最终纳入80例轻中度ARDS患者,SIMV+PSV组40例,AMV+IntelliCycle组40例。
  • 主要结局:与SIMV+PSV相比,AMV+IntelliCycle缩短机械通气时间(106.35±55.03 h vs 136.50±73.78 h)、减少呼吸机报警次数(10.35±5.87次 vs 13.93±6.87次)和手动操作次数(4.25±2.01次 vs 6.83±3.75次)、降低机械功率(12.88±4.67 J/min vs 16.35±5.04 J/min),均P<0.05;AMV+IntelliCycle组PaCO2显著高于SIMV+PSV组(41.58±6.81 mmHg vs 38.45±5.77 mmHg,P<0.05)。
  • 次要结局:两组呼吸频率均随通气时间延长显著改善(时间效应F=4.131,P=0.005),AMV+IntelliCycle组呼吸频率维持更优(干预效应F=5.008,P=0.031),无交互效应(F=2.489,P=0.055);VE、PIP、P0.1、Cst两组间无显著差异(干预效应F值分别为3.343、2.047、0.496、1.456,均P>0.05),但均随通气时间延长显著改善(时间效应F值分别为2.923、12.870、23.120、7.851,均P<0.05),无交互效应(F值分别为1.571、1.291、0.300、0.354,均P>0.05);VT、WOB、时间常数两组间及随时间变化均无显著差异(时间效应F值分别为0.613、1.049、2.087,均P>0.05;干预效应F值分别为1.459、0.514、0.923,均P>0.05)。

证据类型、等级与局限

  • 证据类型:随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于轻中度ARDS患者,AMV+IntelliCycle模式可缩短机械通气时间、降低机械功率并减少报警与手动操作次数,但PaCO2较SIMV+PSV模式更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To verify the clinical safety and efficacy of new intelligent ventilation mode adaptive minute ventilation (AMV)+IntelliCycle ventilation in patients with mild-to-moderate acute respiratory distress syndrome (ARDS).

METHODS: The patients with mild-to-moderate ARDS, admitted to intensive care unit (ICU) of the First Affiliated Hospital of Jinzhou Medical University from February 2018 to February 2019, were enrolled in the study. The patients were divided into synchronous intermittent mandatory ventilation+pressure support ventilation (SIMV+PSV) group and AMV+IntelliCycle group according to the random number table method. All patients were given mechanical ventilation, anti-infection, analgesia and sedation, nutritional support and symptomatic treatment of primary disease after admission. SV800 ventilator was used for mechanical ventilation. In the AMV+IntelliCycle group, after setting the minute ventilation volume (VE), inhaled oxygen concentration (FiO2) and positive end expiratory pressure (PEEP), the ventilator was turned on the full-automatic mode, and the preset value of VE percentage was 120%. In the SIMV+PSV group, the ventilator parameters were set as follows: the ventilation frequency was 12-20 times/min, the inspiratory expiratory ratio was 1:1-2, the peak inspiratory pressure (PIP) limit level was 35-45 cmH2O (1 cmH2O = 0.098 kPa), and the setting of FiO2 and PEEP was as the same as that of AMV+IntelliCycle group, the triggering flow was set to 2 L/min. All of the clinical parameters between the two groups were compared. The main outcomes were duration of mechanical ventilation, ventilator alarm times, manual operation times, and the mechanical power; the secondary outcomes were respiratory rate (RR), VE, tidal volume (VT), PIP, mouth occlusion pressure (P0.1), static compliance (Cst), work of breathing (WOB), and time constant at 0, 6, 12, 24, 48, 72, and 120 hours; and the blood gas analysis parameters of patients before and after ventilation were recorded.

RESULTS: A total of 92 patients with mild-to-moderate ARDS were admitted during the study period, excluding those who quit the study due to death, abandonment of treatment, accidental extubation of tracheal intubation and so on. Eighty patients were finally enrolled in the analysis, with 40 patients in SIMV+PSV group and AMV+IntelliCycle group respectively. (1) Results of main outcomes: compared with the SIMV+PSV mode, AMV+IntelliCycle ventilation mode could shorten the duration of mechanical ventilation (hours: 106.35±55.03 vs. 136.50±73.78), reduce ventilator alarm times (times: 10.35±5.87 vs. 13.93±6.87) and the manual operations times (times: 4.25±2.01 vs. 6.83±3.75), and decrease the mechanical power (J/min: 12.88±4.67 vs. 16.35±5.04, all P < 0.05). But the arterial partial pressure of carbon dioxide (PaCO2) of AMV+IntelliCycle group was significantly higher than that of SIMV+PSV group [mmHg (1 mmHg = 0.133 kPa): 41.58±6.81 vs. 38.45±5.77, P < 0.05]. (2) Results of secondary outcomes: the RR of both groups was improved significantly with the prolongation of ventilation time which showed a time effect (F = 4.131, P = 0.005). Moreover, compared with SIMV+PSV mode, AMV+IntelliCycle mode could maintain a better level of RR, with intervention effect (F = 5.008, P = 0.031), but no interaction effect was found (F = 2.489, P = 0.055). There was no significant difference in VE, PIP, P0.1 or Cst between the two groups, without intervention effect (F values were 3.343, 2.047, 0.496, 1.456, respectively, all P > 0.05), but they were significantly improved with the prolongation of ventilation time in both groups, with time effect (F values were 2.923, 12.870, 23.120, 7.851, respectively, all P < 0.05), but no interaction effect was found (F values were 1.571, 1.291, 0.300, 0.354, respectively, all P > 0.05). The VT, WOB or time constant in both groups showed no significant changes with the prolongation of ventilation time, and no significant difference was found between the two groups, there was neither time effect (F values were 0.613, 1.049, 2.087, respectively, all P > 0.05) nor intervention effect (F values were 1.459, 0.514, 0.923, respectively, all P > 0.05).

CONCLUSIONS: AMV+IntelliCycle ventilation mode can shorten the ventilation time of patients with mild-to-moderate ARDS, reduce mechanical power, and reduce the workload of medical care, but PaCO2 in the patients with AMV+IntelliCycle mode is higher than that in the patients with SIMV+PSV mode.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu Z, Di X, Zhong L, et al. [Clinical application of adaptive minute ventilation + IntelliCycle ventilation mode in patients with mild-to-moderate acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32148226. doi:10.3760/cma.j.cn121430-20191012-00004

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。